Engstrom, Lars D <br/><br/>
Glesatinib Exhibits Antitumor Activity in Lung Cancer Models and Patients Harboring   [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Nov 2017 
 - 6661-6672 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-17-1192  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Benzeneacetamides--pharmacology<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Cell Line, Tumor<br/>Crizotinib<br/>Drug Resistance, Neoplasm--drug effects<br/>Exons--genetics<br/>Female<br/>Humans<br/>Liver Neoplasms--drug therapy<br/>Male<br/>Mice<br/>Middle Aged<br/>Mutation<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins c-met--antagonists & inhibitors<br/>Pyrazoles--administration & dosage<br/>Pyridines--administration & dosage<br/>Xenograft Model Antitumor Assays